Literature DB >> 26211569

Middle East respiratory syndrome coronavirus (MERS-CoV): A cluster analysis with implications for global management of suspected cases.

Ziad A Memish1, Jaffar A Al-Tawfiq2, Rafat F Alhakeem3, Abdullah Assiri3, Khalid D Alharby4, Maher S Almahallawi4, Mohammed Alkhallawi4.   

Abstract

Since the initial description of the Middle East respiratory syndrome (MERS) in September 2012, a total of 1038 cases of MERS-CoV including 460 deaths have been reported from Saudi Arabia. From August 24, 2013 to September 3, 2013, a total of 397 patients and contacts were tested for MERS-CoV. Of those tested, there were 18 (4.5%) MERS-CoV cases reported in Al-Madinah al-Munawwarah with one large cluster. In this report, we describe the outcome, epidemiology and clinical characteristics of this cluster of which 4 cases involved healthcare workers. Fourteen cases appeared to be linked to one cluster involving healthcare workers (HCWs), family and patient contacts. Of the 18 cases, five (including 2 HCWs) were community acquired, two were household contacts, and 11 were healthcare associated (including 4 HCWs). All except 4 cases were symptomatic and the case fatality rate was 39% (7 of 18). The outbreak resulted in human to human transmission of an estimated 6 cases. Contact screening showed positive test in 1 of 56 (1.8%) household contacts, and 3 of 250 (1.2%) HCWs.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clusters; Coronavirus; MERS-CoV; Middle East; RT-PCR

Mesh:

Year:  2015        PMID: 26211569      PMCID: PMC7110629          DOI: 10.1016/j.tmaid.2015.06.012

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


Introduction

Since Middle East respiratory syndrome (MERS) was described in September 2012, a total of 1038 cases of MERS-CoV including 460 deaths have been reported from Saudi Arabia [1]. The current case fatality rate is lower than the initial rate of 65% [2]. MERS-CoV is known to cause three patterns of transmissions [2], [3], [4], [5], [6], [7], [8]: sporadic cases, community-transmission [9] and healthcare associated transmissions such as the case in the Zarqa, Jordan [10], [11], Al-Hasa, Saudi Arabia [12] and Jeddah, Saudi Arabia [13], [14]. The exact source of the infection for most patients remains unknown. In this report, we describe the outcome, epidemiology and clinical characteristics of this cluster of MERS-CoV in Al-Madinah al-Munawwarah of which 4 cases involved healthcare workers.

Methods

All samples were tested in Jeddah regional lab. We included all MERS-CoV cases reported from Al-Madinah al-Munawwarah between August 24, 2013 and September 3, 2013. A confirmed case of MERS CoV is defined as an isolation of MERS CoV from a nasopharyngeal or a respiratory sample by real time reverse transcriptase PCR, as described previously [12], [15]. Clinical information included demographic data, clinical symptoms and signs, co-morbidities, and contact with animals.

Results

MERS-CoV cases and clusters

During the study period, a total of 397 patients and contacts were tested for MERS-CoV. There were 18 (4.5%) MERS-CoV positive cases reported in Al-Madinah al-Munawwarah with one large cluster. Of those cases, 15 (83%) were male and 3 (17%) were females. Twelve of the cases were Saudis (67%) and 6 were non-Saudis 33%. There were two possible clusters and two cases were sporadic in nature. The largest cluster included 15 cases and was thought to be initiated by a 55 year-old male resident. He was in the same hospital ward of a 74 year-old Saudi male who was thought to acquire the infection in the healthcare setting. Transmission then occurred in an additional 12 cases as illustrated in Fig. 1 . Another case was from Qatar, the son of a patient sharing a room with the second case although the father tested negative for MERS-CoV. The second cluster was from the city of Hanakia located 100 km from Madina, and involved a 56 year-old male healthcare worker (HCW), who then infected another 39 year-old HCW. There was one sporadic case, a 50 year-old HCW, who had no contacts with other cases. The majority of the cases (61.1%) were healthcare associated infections and primary cases constituted 27.8% and intra-familial transmission was only 11.1%.
Figure 1

Summary of Cluster of MERS-CoV cases.

Summary of Cluster of MERS-CoV cases.

Case fatality and comorbidity

The case fatality rate was 39% (7 of 18 cases). Of the 14 symptomatic cases, 11 (78.5%) had at least two of the following chronic diseases: diabetes mellitus, hypertension, end stage renal disease, cardiac disease, sickle cell anemia, obesity, or smoking. Only one patient had contact with animals, he was a healthcare worker and was asymptomatic.

Clinical symptoms

All of the 14 symptomatic cases had fever (100%), 64% had shortness of breath, 50% had cough, 35% had nausea, 35% headache, and 21% had sore throat.

Contacts screening

A total of 250 HCWs were screened and 4 (1.6%) were positive. In addition, 56 family contacts were screened and 1 (1.8%) was positive.

Discussion

The current report illustrates the pattern of transmission of MERS-CoV. Our data harmonizes with the previously described pattern of transmission of MERS-CoV [2], [3], [4], [5], [6], [7], [8]. The majority of the patients (61.1%) were healthcare associated infections and primary cases constituted 27.8% and intra-familial transmission was only 11.1%. The recent Jeddah outbreak in 2014 was documented to be secondary to intra-hospital and inter-hospital transmissions [13], [14]. Fig. 2 shows major MERS-CoV outbreaks in Kingdom of Saudi Arabia. The rate of community infections seem to be low with expansion of the infection in the healthcare setting [5]. Animal contact, especially with camels is uncommon among primary cases, and in our series only one patient had camel contact [3], [7]. The case fatality of these cases was 39%, compared to the overall case fatality in KSA of 44% [1] Of the 14 symptomatic cases, 78.5% had at least two of underlying chronic diseases. The presence of comorbidities predisposes to increased risk of MERS-CoV and was shown to also correlate with case fatality rates [16]. Screening of contacts yielded less than 2% positivity among HCWs and family contacts. In a large screening of contacts, MERS-CoV was detected in 1.12% of HCWs contacts and in 3.6% of family contacts [15]. However, the majority of the cases were acquired within healthcare facilities similar to the Al-Hasa and Jeddah outbreak [12], [13], [14]. An interesting observation in this report is the link of one of the MERS cases from Qatar to this healthcare associated cluster. Travel associated MERS cases were reported from: Turkey, Austria, United Kingdom, Germany, France, Greece, the Netherlands, Tunisia, Algeria, Malaysia, Philippines, China, and the United States of America [17]. The recent occurrence of an outbreak in the Republic of Korea was started with a returning traveler [17], [18], [19]. The patient traveled to Bahrain (18–29 April), the United Arab Emirates (29–30 April), Bahrain (30 April–1 May), Saudi Arabia (1–2 May), Bahrain (2 May) and Qatar (2–3 May) [17], [19]. The outbreak spanned 72 healthcare facilities which have treated patients and six healthcare facilities have documented nosocomial transmission [19]. As of June 24, 2015, this outbreak had caused 179 cases including 27 deaths [19]. The outbreak highlights the importance of infection control and early recognition and isolation of suspected cases [5]. The Kingdom of Saudi Arabia also hosts one of the largest mass gathering in the world hosting millions of pilgrims during the annual Hajj where pilgrims visit the holly cities of Makkah and Al-Madinah [7]. The occurrence of MERS-CoV transmission during the annual Hajj and subsequent development of a global epidemic is of a great concern. Respiratory samples were obtained from all MERS suspected cases during 2013 Hajj season and all samples tested negative for MERS-CoV [20]. A cohort of 129 French Hajj pilgrims were systematically sampled in 2013 with screened for MERS-CoV using nasal swabs prior to returning to France [21]. Although, the majority (90.7) had respiratory symptoms, none was tested positive for MERS-CoV [21]. In 2012 and 2013 Hajj season, a total of 5 million pilgrims from 184 countries visited Makkah and Al-Madinah and no cases of MERS-CoV were detected during or after the Hajj [22]. Screening of 5235 adult pilgrims from 22 countries in 2013 showed no positive MERS cases using nasopharyngeal swabs [23]. Although only rare cases have been associated with the Umrah pilgrimage so far, there is a need for continuing surveillance among travelers, pilgrims and HCW attending pilgrims [24].
Figure 2

A map of the Kingdom of Saudi Arabia showing main clusters: Riyadh (The Capital); Hofof (Al-Hasa 2013 outbreak); Jeddah (2014 outbreak); and the holy Cities Makkah and Al-Madinah (the described outbreak in this report).

A map of the Kingdom of Saudi Arabia showing main clusters: Riyadh (The Capital); Hofof (Al-Hasa 2013 outbreak); Jeddah (2014 outbreak); and the holy Cities Makkah and Al-Madinah (the described outbreak in this report).

Conflict of interest

None.
  19 in total

Review 1.  An update on Middle East respiratory syndrome: 2 years later.

Authors:  Jaffar A Al-Tawfiq; Ziad A Memish
Journal:  Expert Rev Respir Med       Date:  2015-03-19       Impact factor: 3.772

2.  Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation.

Authors:  B Hijawi; M Abdallat; A Sayaydeh; S Alqasrawi; A Haddadin; N Jaarour; S Alsheikh; T Alsanouri
Journal:  East Mediterr Health J       Date:  2013       Impact factor: 1.628

3.  Family cluster of Middle East respiratory syndrome coronavirus infections.

Authors:  Ziad A Memish; Alimuddin I Zumla; Rafat F Al-Hakeem; Abdullah A Al-Rabeeah; Gwen M Stephens
Journal:  N Engl J Med       Date:  2013-05-29       Impact factor: 91.245

Review 4.  Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers.

Authors:  Jaffar A Al-Tawfiq; Alimuddin Zumla; Ziad A Memish
Journal:  Curr Opin Infect Dis       Date:  2014-10       Impact factor: 4.915

5.  Hospital outbreak of Middle East respiratory syndrome coronavirus.

Authors:  Abdullah Assiri; Allison McGeer; Trish M Perl; Connie S Price; Abdullah A Al Rabeeah; Derek A T Cummings; Zaki N Alabdullatif; Maher Assad; Abdulmohsen Almulhim; Hatem Makhdoom; Hossam Madani; Rafat Alhakeem; Jaffar A Al-Tawfiq; Matthew Cotten; Simon J Watson; Paul Kellam; Alimuddin I Zumla; Ziad A Memish
Journal:  N Engl J Med       Date:  2013-06-19       Impact factor: 91.245

Review 6.  Middle East respiratory syndrome coronavirus: epidemiology and disease control measures.

Authors:  Jaffar A Al-Tawfiq; Ziad A Memish
Journal:  Infect Drug Resist       Date:  2014-11-03       Impact factor: 4.003

Review 7.  Travel implications of emerging coronaviruses: SARS and MERS-CoV.

Authors:  Jaffar A Al-Tawfiq; Alimuddin Zumla; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2014-07-09       Impact factor: 6.211

8.  Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description.

Authors:  Mohammad Mousa Al-Abdallat; Daniel C Payne; Sultan Alqasrawi; Brian Rha; Rania A Tohme; Glen R Abedi; Mohannad Al Nsour; Ibrahim Iblan; Najwa Jarour; Noha H Farag; Aktham Haddadin; Tarek Al-Sanouri; Azaibi Tamin; Jennifer L Harcourt; David T Kuhar; David L Swerdlow; Dean D Erdman; Mark A Pallansch; Lia M Haynes; Susan I Gerber
Journal:  Clin Infect Dis       Date:  2014-05-14       Impact factor: 9.079

9.  Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj.

Authors:  Ziad A Memish; Abdullah Assiri; Malak Almasri; Rafat F Alhakeem; Abdulhafeez Turkestani; Abdullah A Al Rabeeah; Jaffar A Al-Tawfiq; Abdullah Alzahrani; Essam Azhar; Hatem Q Makhdoom; Waleed H Hajomar; Ali M Al-Shangiti; Saber Yezli
Journal:  J Infect Dis       Date:  2014-03-11       Impact factor: 5.226

10.  Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms.

Authors:  P Gautret; R Charrel; K Belhouchat; T Drali; S Benkouiten; A Nougairede; C Zandotti; Z A Memish; M al Masri; C Gaillard; P Brouqui; P Parola
Journal:  Clin Microbiol Infect       Date:  2013-03-02       Impact factor: 8.067

View more
  19 in total

1.  Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.

Authors:  Wanbo Tai; Yufei Wang; Craig A Fett; Guangyu Zhao; Fang Li; Stanley Perlman; Shibo Jiang; Yusen Zhou; Lanying Du
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

2.  Modeling the Transmission of Middle East Respirator Syndrome Corona Virus in the Republic of Korea.

Authors:  Zhi-Qiang Xia; Juan Zhang; Ya-Kui Xue; Gui-Quan Sun; Zhen Jin
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

Review 3.  Vaccines for the prevention against the threat of MERS-CoV.

Authors:  Lanying Du; Wanbo Tai; Yusen Zhou; Shibo Jiang
Journal:  Expert Rev Vaccines       Date:  2016-04-06       Impact factor: 5.217

4.  A pandemic risk assessment of middle east respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia.

Authors:  Saleh A Eifan; Islam Nour; Atif Hanif; Abdelrahman M M Zamzam; Sameera Mohammed AlJohani
Journal:  Saudi J Biol Sci       Date:  2017-06-06       Impact factor: 4.219

5.  Efficacy of an Automated Multiple Emitter Whole-Room Ultraviolet-C Disinfection System Against Coronaviruses MHV and MERS-CoV.

Authors:  Kurt Bedell; Adam H Buchaklian; Stanley Perlman
Journal:  Infect Control Hosp Epidemiol       Date:  2016-01-28       Impact factor: 3.254

6.  Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate.

Authors:  Zachary J Madewell; Yang Yang; Ira M Longini; M Elizabeth Halloran; Natalie E Dean
Journal:  medRxiv       Date:  2020-07-31

7.  Epidemiology and predictors of survival of MERS-CoV infections in Riyadh region, 2014-2015.

Authors:  Fahad S Al-Jasser; Randa M Nouh; Randa M Youssef
Journal:  J Infect Public Health       Date:  2018-10-16       Impact factor: 3.718

8.  Middle East Respiratory Syndrome Coronavirus and the One Health concept.

Authors:  Maged Gomaa Hemida
Journal:  PeerJ       Date:  2019-08-22       Impact factor: 2.984

Review 9.  Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature.

Authors:  J A Al-Tawfiq; P G Auwaerter
Journal:  J Hosp Infect       Date:  2018-06-01       Impact factor: 3.926

Review 10.  Drivers of MERS-CoV transmission: what do we know?

Authors:  Jaffar A Al-Tawfiq; Ziad A Memish
Journal:  Expert Rev Respir Med       Date:  2016       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.